Tired of telling patients to go to WebMD.com or…yawn…NIMH.nih.gov for their Internet information needs? Here are some alternatives that will probably keep your patients a little more engaged, and as a result, more educated.
Read More
Dr. Luo, there are so many forms of electronic communication out there now—from email to blogs to Twitter. What do psychiatrists need to know about using technology to communicate with our patients?
Read More
Scopolamine is an anticholinergic most often used in patch form to prevent sea-sickness or post-surgical nausea. A recent double-blind, placebo-controlled trial looked at intravenous scopolamine’s effects as a treatment for unipolar depression.
Read More
We have often heard that bipolar disorder is frequently underdiagnosed, leading to inappropriate treatments. This idea has been confirmed in several studies, but the plot has thickened—research also suggests that bipolar disorder is being overdiagnosed in some settings.
Read More
Telepsychiatry is a sub-field of telemedicine that refers to the use of videoconferencing to treat patients in other locations. This used to be an expensive proposition, requiring special videoconferencing equipment, but now anybody with a modern laptop computer and a webcam can videoconference...
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...